BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 24942492)

  • 1. Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus.
    Tamashiro LF; Oliveira RD; Oliveira R; Frota ER; Donadi EA; Del-Ben CM; Teixeira AL; Louzada-Junior P
    Rheumatology (Oxford); 2014 Dec; 53(12):2182-90. PubMed ID: 24942492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral levels of brain-derived neurotrophic factor and S100B in neuropsychiatric systemic lupus erythematous.
    Noris-García E; Arce S; Nardin P; Lanigan ME; Acuña V; Gutierrez F; Robinson-Agramonte MA; Gonçalves CA
    Lupus; 2018 Nov; 27(13):2041-2049. PubMed ID: 30376438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
    Ikenouchi-Sugita A; Yoshimura R; Okamoto T; Umene-Nakano W; Ueda N; Hori H; Katsuki A; Saito K; Tanaka Y; Nakamura J
    World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum BDNF and cognitive dysfunction in SLE: findings from a cohort of 111 patients.
    Alessi H; Dutra LA; Maria LA; Coube PC; Hoshino K; de Abrantes FF; Lopes FC; de Souza AWS; Kayser C; Barsottini OGP
    Clin Rheumatol; 2022 Feb; 41(2):421-428. PubMed ID: 34537904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
    Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Cell Neurotrophin Production Is Associated with Subcortical Brain Atrophy in Neuropsychiatric Systemic Lupus Erythematosus Patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Wyciszkiewicz A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Paprzycki W; Kozubski W; Michalak S
    Neuroimmunomodulation; 2017; 24(6):320-330. PubMed ID: 29539621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosus.
    Podrazilová L; Peterová V; Olejárová M; Tegzová D; Krásenský J; Seidl Z; Kozelek P; Dostál C
    Clin Exp Rheumatol; 2008; 26(4):604-10. PubMed ID: 18799091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microparticles in neuropsychiatric systemic lupus erythematosus.
    Crookston KP; Sibbitt WL; Chandler WL; Qualls CR; Roldan CA
    Int J Rheum Dis; 2013 Feb; 16(1):72-80. PubMed ID: 23441775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood brain-derived neurotrophic factor level and tyrosine kinase B expression on T lymphocytes in systemic lupus erythematosus: Implications for systemic involvement.
    Tian B; Yang C; Wang J; Hou X; Zhao S; Li Y; Yang P
    Cytokine; 2019 Nov; 123():154764. PubMed ID: 31255912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
    Fang H; Lan L; Qu Y; Zhang Q; Lv J
    J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is serum TWEAK a useful biomarker of neuropsychiatric systemic lupus erythematosus?
    Balajkova V; Olejarova M; Moravcova R; Kozelek P; Posmurova M; Hulejova H; Senolt L
    Physiol Res; 2020 Apr; 69(2):339-346. PubMed ID: 32199014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of brain-derived neurotrophic factor are associated with depressive symptoms in patients with systemic lupus erythematosus.
    Zheng Q; Xu MJ; Cheng J; Chen JM; Zheng L; Li ZG
    Psychoneuroendocrinology; 2017 Apr; 78():246-252. PubMed ID: 28237708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical manifestations, laboratory test, treatment and outcome of neuropsychiatric involvement in pediatric systemic lupus erythematosus patients].
    Wu XY; Song HM; Zeng XF; He YY; Wang W; Li F; Guo YZ; Wei M
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):286-90. PubMed ID: 19555568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.